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Abstrack
Background: Trisomy 13 is a trisomy disorder of chromosome 13 which causes many fetal structural defects. The 
prognosis is very poor and the majority is still birth. Major structural anomalies are occasionally identified in 
the late-first or early-second trimester. Any discovery of multiple structural anomalies in the fetus increases the 
chances of chromosomal anomalies. 
Case Report: Here we report trisomy 13 case of A 34-years-old housewife, third gravida, prenatal diagnosis during 
antenatal ultrasonography showed diaphragmatic hernias, cardiovascular dextroposition, ventricular septal 
defect, labiognatopalatoschizis and renal dextra pyeletaxis. From the chromosomal analysis, the fetal karyotype 
was 47 XY+13. A male infant was born with weight of 2600 grams, 46 cm, cyanosis, and severe respiratory distress 
with congenital abnormalities of micrognathia, diaphragmatic hernia, dextrocardia, ventricular septal defect, 
persistent pulmonary hypertension of newborn, undescended testis, labiognatopalatoshizis, and polydactily. 
Discussion: Prenatal diagnosis can be done through amniocentesis for karyotyping which is the gold standard for 
diagnosis trisomy 13. In addition, screening can also be done since the first trimester.
Conclusion: All pregnancies in second trimester must be evaluated for structural abnormalities through 
ultrasonography and cytogenetic examination if necessary for early diagnosed.
Key word: Congenital Abnormalities, Ultrasonography, Clinical Finding, Trisomy 13, Patau Syndrome
Gambaran Ultrasonografi dan Klinis Kehamilan dengan Janin Trisomi 13 
(Sindrom Patau): Laporan Kasus
Abstrak
Latar Belakang: Trisomi 13 merupakan kelainan jumlah kromosom 13 yang menyebabkan defek struktural pada 
fetus. Prognosisnya sangat buruk dan kebanyakan lahir mati. Kelainan struktural mayor sering teridentifikasi 
pada akhir trimester pertama atau awal trimester kedua. Setiap temuan kelainan struktural pada fetus berpotensi 
kelainan kromosom.
Laporan Kasus: Di sini akan dijelaskan kasus trisomi 13 yang didiagnosis prenatal dari wanita G3P1011, 34 
tahun, terdiagnosis melalui pemeriksaan ultrasonografi. Antenatal scan dilakukan pada usia kehamilan 21 
minggu dan gambaran ultrasonografi menunjukkan hernia diafragmatika, dextrokardia, ventricular septal defect, 
labiognatopalatoschizis dan pielektasis ginjal kanan. Kemudian dilanjutkan pemeriksaan kromosom melalui 
amniosintesis dan didapatkan hasil 47 XY+13.  Bayi laki-laki lahir secara sectio secarea dengan berat 2600 gram, 
panjang badan 46 cm, sianosis, asfiksia berat, kelainan kongenital micrognatia, hernia diafragmatika, dextrokardia, 
defek septum ventrikular, hipertensi pulmonal, labiognatopalatoshizis, dan polidactili. 
Diskusi: Diagnosis prenatal dapat dilakukan melalui pemeriksaan amniosintesis bertujuan untuk melihat 
karyotyping yang merupakan gold standard untuk mendiagnosis  trisomi 13. Selain itu, screening juga dapat 
dikerjakan sejak trimester pertama.
Kesimpulan: Semua kehamilan pada trimester kedua harus dievaluasi kelainan struktural melalui ultrasonografi 
dan bila perlu pemeriksaan sitogenetik sehingga dapat mendiagnosis lebih awal.




Trisomy 13 or Patau syndrome is a trisomy 
disorder. It is due to the presence of a whole 
extra copy of chromosome 13. Trisomy 13 is 
the third most common autosomal trisomy, 
after trisomy 21 (Down syndrome) and 18 
(Edwards syndrome) with the prevalence of 
birth in region of 1 in 5,000 to 1 in 20,000. 
The incidence of trisomy 13 varies across 
countries in Europe, America and Asia. In 
Asia, for example in Malaysia, the incidence 
of congenital anomalies is 1 in 838 live 
births. The incidence of trisomy 13 is 2.6 
per 10,000 births. The poor prognosis that 
exists for infants born with trisomy 13, 
Patau syndrome, has been well known and 
documented over the last forty years. It is 
also clear that the survival rates for this 
condition has not changed greatly during that 
time period. What has changed dramatically 
during this period of time is the ability 
to diagnose trisomy 13 prenatally, using 
ultrasound clinically indicated screening or 
assesstment, and invasive diagnostic testing 
such as chorionic villous sampling and 
amniocentesis.1,2 
In recent years, there appears to be 
a significant increase in the prevalence 
of pregnancies with trisomy 13, this may 
be related to an increase in maternal age 
observed in many developed countries. As 
this is generally a lethal condition, when 
confronted with this diagnosis prenatally, it 
is important to counsel parents accurately 
about the ultimate prognosis, and likelihood 
of intrauterine, neonatal or infant death, or 
long-term survival.1,3
There are no known risk factors of 
trisomy 13 except previous history of any 
affected fetus. So suspicion only occurs during 
routine second-trimester ultrasound scanning 
showing multiple fetal structural anomalies 
confirmed by cytogenetic examination, 
which may reveal the diagnosis. Among 
structural anomalies, 80% are cardiac defects 
which include patent ductus arteriosus, 
ventricular septal defect, atrial septal defect, 
and dextrocardia.3
The prognosis of infants with trisomy 13 
is very poor and the majorities are still birth. 
Some infants are born but do not last long. 
Approximately 80% of live-born infants die 
on the first day, and the mortality rate of 
neonatal death within 1 week of life is more 
than 90% .3 Some infants survived in the first 
six-months usually die of heart failure or 
concurrent infection. Most died before age of 
one year; less than 10% can survive in the 
first year. 2
Case Report
A 34-years-old Balinese housewife, a third 
gravida with 1 child alive and previous 
pregnancies with intrauterine death. It was 
a planned pregnancy and her LMP was on 
September 16, 2017. Antenatal examination 
was performed at 21 weeks of pregnancy 
revealed multiple structural abnormalities 
as diaphragmatic hernias, cardiovascular 
dextroposition, ventricular septal defect, 
labiognatopalatoschizis and renal dextra 
pyeletaxis. For this reason, she was advised 
amniocentesis for karyotyping.  She did 
amniocentesis and karyotyping on March 27, 
2018 (27 weeks of gestation) showing 47Y + 
13. Due to multiple congenital anomalies in 
the fetus, multidiciplinary approached with 
neonatology, cardiology and pediatric surgery 
divisions was performed. It is planned for 
sectio cesarean at 37 weeks of gestation with 
the expectation to correct the diaphragmatic 
hernia for saving the baby’s life.
 Previous history of pregnancy, the first child 
was delivered vaginally in 2011 at term with 
birth weight 3200 grams, and the second one 
was stillbirth in 2016. She had no medical 
history or in any treatment.
On June 2, 2018,  patient came to the 
emergency ward of Sanglah Hospital 
and complained of labor pain. Physical 
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examination showed her body weight was 
70 kg, BMI was 27.3 kg/ m2, blood pressure 
120/80 mmHg, and pulse rate 80 bpm. 
Obstetric examination showed symphysio-
fundal height of 28 cm, single fetus in 
longitudinal lie, cephalic presentation, and 
fetal heart rate of 165 bpm. It was also found 
uterine contraction of 3-4 times in 10 minutes 
with duration of 30-40 seconds. From vaginal 
toucher examination, cervix dilatation 
Figure 1 Ultrasonography scan of second trimester with 




was 2 cm. Emergency section secarea was 
performed. At 6:19 pm, a male infant was born 
with weight of 2600 grams, 48 cm in length, 
and head circumference of 32 cm, cyanosis, 
SaO2 60%, and hypotonic. On auscultation, 
the heart rate was 55 beats per minute, the 
systolic murmur on parasternal line dextra, 
the bowel sounds in left hemithorax. Further, 
it was noted that he had micrognathia, 
diaphragmantic hernia, dextrocardia, 
ventricular septal defect, persistent pulmonary 
hypertension of newborn, undecended testis, 
labiognatopalatoshizis, and polydactily.
In postnatal period, maternal blood pressure 
increased postsurgery with blood pressure 
of 150/100 mmHg, then urinalysis showed 
proteinuria (-).
Figure 2 Cytogenetic result showed 
kariotype of trisomy 13
 
Figure 3 Congenital anomaly with microg- 
nathia, labiognatopalatoskizis, 
polydactily, and undescended 
testis.
Discussion
Trisomy 13 occurs due to non-disjunction 
during meiotic division. Trisomy 13 can be 
diagnosed prenatally. Prenatal diagnosis 
is performed when pregnancy has a risk 
of congenital abnormalities in the fetus, 
especially history of having children with 
congenital abnormalities and increasing 
maternal age. 5,6,7
The prenatal diagnosis of trisomy 13 
involves first and second trimester screening 
and by invasive diagnostic methods 
such as chorionic villus sampling (CVS) 
or amniocentesis.8  Amniocentesis was 
performed for karyotyping study. Karyotyping 
is the gold standard for diagnosing trisomy 
13.12 To minimize the number of procedures, 
screening can be done by non-invasive 
methods that include ultrasound and 
biochemical analysis of maternal serum can 
be done since the first trimester.6,7
In this case, there was a risk factor of 
previous intrauterine fetal death (IUFD). 
So initial screening is needed since the 
first trimester to find out any chromosomal 
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abnormalities. This patient examined 
her pregnancy in the second trimester 
where the ultrasonography showed 
labiognatopalatoskizis, ventricular septal 
defect, diaphragmatic hernia, and pyeletaksis 
renal dextra. To establish a definitive diagnosis 
of whether the fetus has chromosomal 
abnormalities, amniocentesis was needed. 
Due to the limited facilities in karyotyping 
examination in our center,  samples were sent 
to more adequate laboratory and the result 
was 47XY + 13 suitable for trisomy 13 after 
the baby was born.
After the diagnosis of trisomy 13 is 
established, the management of pregnancy 
varies according to the gestational age at 
that time. At pre-viable gestational age, 
termination of pregnancy is an option. As the 
pregnancy has developed, attention should be 
focused on the method of labor. The decision 
about the method of delivery is determined 
by obstetrical considerations and does not 
depend on the presence of the syndrome. 
Cesarean delivery is not recommended due to 
lethal condition. The entire management plan 
should include discussion with neonatologist 
on neonatal resuscitation procedures, cost, 
and alternatives to aggressive resuscitation.2
In our cases, the couple was counseled 
about the prognosis. The parents decided to 
continue the pregnancy. Based on congenital 
abnormalities from ultrasonography in these 
patients, a multidisciplinary discussion 
with neonatology, cardiology and pediatric 
surgery about the appropriate method of 
delivery was performed, and it was decided 
to do a cesarean delivery with expectation we 
could do correction of diaphragmatica hernia 
soon after the baby was born to prevent lung 
hypoplasia. 
A multi-state, population-based study 
in 16 European countries on 240 live-born 
infants with trisomy 13 showed that the 
prevalence of anomalies were as follows: 
cardiac anomalies 57%; nervous system 
anomalies 39%; eye anomalies 30%; 
polydactyly 44%; and orofacial cleft 45%.9 
Among the structural anomalies, 80% are 
cardiac defects which include patent ductus 
arteriosus, ventricular septal defect, atrial 
septal defect and dextrocardia.3 Other 
disorders include neural tube defects, 
especially cephalocele, microphthalmia, cleft 
lip and palate, omphalocele, cystic dysplasia 
of the kidneys, polydactyly, rocker-bottom 
feet, and aplasia of the skin area.2
In this case, a male baby with severe 
asphyxia was born. On examination, the baby 
was noted to have multiple dysmorphic features 
consistent with Patau syndrome, including 
micrognathia, labiognatopalatoshizis, 
diaphragmatic hernia, dextrocardia, asianotic 
congenital heart disease of ventricular septal 
defect, persistent pulmonary hypertension of 
newborn, undecensus testis, and polydactily. 
Congenital heart defects are frequent among 
patients with trisomy 13 and echocardiography 
should be offered to all individuals, even to 
those without cardiac symptoms. The most 
common defects is septal defect. The survival 
time also does not seem to be different between 
patients with and without septal defects. 12 
This clinical sign showed trisomy 13 and 
had been proved by cytogenetic analysis 
from amniocentesis. Medical problems after 
birth depend on congenital abnormalities. 
For example, respiratory difficulty is due 
to pulmonary developmental disorder.8 In 
this case, cardiac echocardiography showed 
pulmonary hypertension, ventricular septal 
defect, a small defect in the atrial, and patent 
ductus arteriosus.
Women who are carrying a trisomy 13 
fetus are prone to have abnormal placenta 
as well as to develop preeclampsia in the 
second and third trimesters. The placental 
abnormalities associated with trisomy 13 
such as small placental volume and reduced 
placental vascularization, will result in 
placental hypoxia and produce sFlt1, then 
excessive expression of sFlt1 resulting in 
preeclampsia. 2,10,11 In this case, the patient 
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regularly doing antenatal care every month 
since second trimester and there is no 
increasing of blood pressure. However, after 
delivery there was a significant increase of 
blood pressure that led to the condition of 
preeclampsia.
The prognosis of infants with trisomy 
13 is very poor and the majority of babies 
are still birth. More than 80% of children 
with trisomy 13 died in the first year. Some 
babies survived the first six months usually 
die because of heart failure or concomitant 
infections. 2,13 In this case the infant was born 
with severe asphyxia conditions accompanied 
by multiple congenital abnormalities. Due to 
respiratory failure, the baby was intubated 
and mechanically ventilated on neonatal 
intensive care unit (NICU). Neonates with 
this syndrome die usually within few hours 
or days of life. So did this baby, survived only 
for 4 days.
Conclusion
Trisomy 13 is a lethal condition. The initial 
diagnosis of this syndrome is important for 
proper management of the patient, including 
monitoring of specific complications. All 
pregnancies in the second trimester should 
be evaluated for structural abnormality 
through ultrasound. Even if cytogenetic 
examination is necessary, it should be done 
as soon as possible. Screening is important, 
especially in high-risk pregnancies such as 
maternal age >35 years and history of having 
fetus with congenital abnormalities. Once 
a diagnosis of Patau syndrome is made, 
discussions about pregnancy management 
and treatment options for neonates with this 
syndrome are urgently needed and should be 
determined immediately if the pregnancy is 
to be continued through prenatal counseling 
to parents with obstetricians, neonatologists, 
clinical geneticists, surgeons, and genetic 
counselors for the treatment and survival 
of infants. Regarding future pregnancy, 
parents should be referred to a geneticist or 
genetic counselor for appropriate counseling 
regarding recurrent risks, etiology and 
prognosis. Recurrent risks depend on the 
details of the chromosome abnormality and 
maternal age. 
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